Form D · Biotechnology
Mosaic Biosciences, Inc.
Boulder, CO · CIK 0001526054
Offering snapshot reported Jan 6, 2023 · SEC filing
- Reported sold
- $11.4M Offering amount: $11.4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2023 | Initial | $11,382,997 | No comparison | 4 | SEC filing |
| Feb 10, 2014 | Initial | $2,274,000 | No comparison | 4 | SEC filing |
| Jul 20, 2011 | Initial | $1,030,462 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-469941
Source: Form D, filed Jan 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rob Capone | Director |
| Eric Furfine | Director |
| Guy Katsav | Director |
| Augustine Lawlor | Director |
| Mark Lupa | Director |
| Dan Mitchell | Director |
| Martin Stanton | Director, Executive |
| Nassim Usman | Director |
| Jeanette Welsh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2830 Wilderness Place
Boulder, CO, 80301
Boulder, CO, 80301